Amrize (NYSE:AMRZ) Insider Purchases $179,386.56 in Stock

Amrize Ltd (NYSE:AMRZ) insider Jaime Hill bought 3,184 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was bought at an average cost of $56.34 per share, for a total transaction of $179,386.56. Following the transaction, the insider owned 26,000 shares of the company’s stock, valued at $1,464,840. The trade was a 13.96% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Jaime Hill also recently made the following trade(s):

• On Wednesday, March 11th, Jaime Hill bought 1,000 shares of Amrize stock. The shares were bought at an average price of $58.91 per share, for a total transaction of $58,910.00.

Amrize Stock Performance

Shares of NYSE AMRZ opened at $56.23 on Friday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64. The stock has a 50 day moving average price of $57.92 and a 200 day moving average price of $53.64. The stock has a market capitalization of $31.10 billion and a PE ratio of 22.86. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94.

Amrize (NYSE:AMRZ) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.03. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.95 billion. The firm’s revenue for the quarter was down .4% on a year-over-year basis.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Oppenheimer restated an “outperform” rating and set a $70.00 target price (up from $64.00) on shares of Amrize in a report on Thursday, February 19th. JPMorgan Chase & Co. increased their price target on shares of Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a research note on Thursday, March 5th. Stephens initiated coverage on shares of Amrize in a research note on Friday, November 14th. They set an “overweight” rating and a $60.00 price objective on the stock. Truist Financial upped their target price on shares of Amrize from $60.00 to $75.00 and gave the company a “buy” rating in a report on Friday, February 20th. Finally, Bank of America set a $58.00 target price on shares of Amrize in a research note on Monday, January 12th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, Amrize presently has a consensus rating of “Moderate Buy” and an average price target of $64.14.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Bank of New York Mellon Corp bought a new stake in Amrize in the 2nd quarter valued at $38,803,000. Metis Global Partners LLC bought a new position in Amrize during the second quarter worth $635,000. Aviva PLC acquired a new position in shares of Amrize in the second quarter valued at $29,836,000. Rathbones Group PLC acquired a new position in shares of Amrize in the second quarter valued at $257,000. Finally, Acadian Asset Management LLC bought a new position in shares of Amrize in the second quarter valued at about $25,590,000.

Amrize News Roundup

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Significant insider buying from senior management (CEO disclosed a multi-million dollar purchase and other executives have added shares), which signals management conviction in the business. Insider Buying: Amrize CEO Acquires Stock
• Positive Sentiment: SEC filings show multiple recent purchases by the CTO, CFO and other insiders — cumulative insider accumulation increases alignment with shareholders. SEC Filing: Insider Transactions
• Positive Sentiment: Institutional buying and favorable analyst coverage (several raises/reaffirms and a “Moderate Buy” consensus) provide a constructive medium‑term backdrop. Brokerages Give AMRZ Moderate Buy
• Neutral Sentiment: Management emphasised an investment‑led growth strategy on the earnings call — positive for long term but may delay margin/near-term revenue improvements. Earnings Call Signals Investment‑Led Growth
• Negative Sentiment: Q4 revenue missed estimates (reported $2.84B vs. ~$2.95B expected) and was slightly down YoY — the top‑line miss is the main near‑term driver of weaker sentiment. MarketBeat: AMRZ Earnings/Revenue Details
• Negative Sentiment: Disclosure of a large increase in CEO compensation (reported jump year‑over‑year) could raise governance concerns for some investors. QuiverQuant: CEO 2025 Pay Revealed
• Negative Sentiment: Today’s pullback appears to be light‑volume and may reflect short‑term profit‑taking or cautious reaction to the revenue miss despite insider buys.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.